Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1046113.RAnF65vguaXx1dKBMR6w7F4AWG7pAW0XwvpVk_sqLjDc4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1046113.RAnF65vguaXx1dKBMR6w7F4AWG7pAW0XwvpVk_sqLjDc4130_assertion type Assertion NP1046113.RAnF65vguaXx1dKBMR6w7F4AWG7pAW0XwvpVk_sqLjDc4130_head.
- NP1046113.RAnF65vguaXx1dKBMR6w7F4AWG7pAW0XwvpVk_sqLjDc4130_assertion description "[Aberrant DNA methylation in DCM patients was associated with significant changes in LY75 and ADORA2A mRNA expression, but not in ERBB3 and HOXB13.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1046113.RAnF65vguaXx1dKBMR6w7F4AWG7pAW0XwvpVk_sqLjDc4130_provenance.
- NP1046113.RAnF65vguaXx1dKBMR6w7F4AWG7pAW0XwvpVk_sqLjDc4130_assertion evidence source_evidence_literature NP1046113.RAnF65vguaXx1dKBMR6w7F4AWG7pAW0XwvpVk_sqLjDc4130_provenance.
- NP1046113.RAnF65vguaXx1dKBMR6w7F4AWG7pAW0XwvpVk_sqLjDc4130_assertion SIO_000772 23341106 NP1046113.RAnF65vguaXx1dKBMR6w7F4AWG7pAW0XwvpVk_sqLjDc4130_provenance.
- NP1046113.RAnF65vguaXx1dKBMR6w7F4AWG7pAW0XwvpVk_sqLjDc4130_assertion wasDerivedFrom befree-2016 NP1046113.RAnF65vguaXx1dKBMR6w7F4AWG7pAW0XwvpVk_sqLjDc4130_provenance.
- NP1046113.RAnF65vguaXx1dKBMR6w7F4AWG7pAW0XwvpVk_sqLjDc4130_assertion wasGeneratedBy ECO_0000203 NP1046113.RAnF65vguaXx1dKBMR6w7F4AWG7pAW0XwvpVk_sqLjDc4130_provenance.